Ginkgo Bioworks Holdings (DNA) Non Operating Income (2021 - 2026)

Ginkgo Bioworks Holdings has reported Non Operating Income for 6 years, with the latest figure at -$4.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 111.78% year-over-year to -$4.8 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (up 44.14% YoY), and the FY2025 full-year result was $1.7 million, down 86.3% from the prior year.
• Non Operating Income for Q1 2026 stood at -$4.8 million, up from -$10.6 million in the prior quarter.
• The five-year high for Non Operating Income was $82.6 million in Q1 2022, with the low at -$33.8 million in Q4 2023.
• Historically, Non Operating Income has averaged $4.0 million across 5 years, with a median of -$1.6 million in 2024.
• Annual changes were most pronounced in 2022 — Non Operating Income sank 552.2% — and 2025, when it soared 688.5%.
• Ginkgo Bioworks Holdings' Non Operating Income stood at $43.0 million in 2022, then plunged by 178.52% to -$33.8 million in 2023, then jumped by 87.41% to -$4.3 million in 2024, then sank by 150.22% to -$10.6 million in 2025, then jumped by 55.22% to -$4.8 million in 2026.
• The last three Non Operating Income figures came in at -$4.8 million (Q1 2026), -$10.6 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.